3.770PLN-1.18%Mkt Cap: 81.98M $P/E: 75.40Today
BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally. The company offers recombinant human insulin; and oral diab…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap81.98M $
Enterprise Value97.18M $
Revenue (TTM)67.37M $
Gross Profit23.25M $
Net Income (TTM)859.31K $
Revenue/Share0.7846 USD
Last Price3.770 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLBIOTN00029
Valuation
P/E (Trailing)75.40
P/E (Forward)—
PEG—
EV/EBITDA7.35
EV/Revenue1.44
P/S1.24
P/B0.56
EPS (TTM)0.05
EPS (Forward)—
52W Range
3.65013% of range4.600
52W High4.600 PLN
52W Low3.650 PLN
Profitability
Gross Margin32.49%
Oper. Margin-8.40%
EBITDA Margin19.62%
Profit Margin1.20%
ROE0.57%
ROA0.44%
Growth
Revenue Growth-25.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF5.73M $
CapEx (TTM)3.31M $
FCF Margin-0.02%
FCF Yield-0.01%
Net Debt14.22M $
Net Debt/EBITDA1.08
Balance Sheet
Debt/Equity0.10
Current Ratio1.35
Quick Ratio0.42
Book Value/Sh6.857 PLN
Cash/Share0.0300 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateJan 13, 2014
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.85.86M
Float38.80M
Insiders56.31%
Institutions0.28%
Technical
SMA 503.882 (-2.9%)
SMA 2004.052 (-7.0%)
Beta0.17
S&P 52W Chg18.16%
Avg Vol (30d)23.86K
Avg Vol (10d)36.59K
Technical Indicators
RSI (14)43.4
MACD-0.0189
MACD Signal-0.0188
MACD Hist.-0.0001
BB Upper3.902 PLN
BB Middle3.841 PLN
BB Lower3.779 PLN
BB Width3.19%
ATR (14)0.0636 PLN
Vol Ratio (20d)1.06x